Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-05-09

Clinical Trial Update: TIMBER Psychotherapy and Ketamine Single Infusion in Chronic PTSD [NA]

View source ↗

Summary

Clinical trial update for TIMBER combining psychotherapy with a single ketamine infusion in chronic PTSD; trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: The Cooper Health System | Conditions: PTSD | NA | Status: UNKNOWN